137 related articles for article (PubMed ID: 10320251)
1. Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action.
Massoudy P; Zahler S; Barankay A; Becker BF; Richter JA; Meisner H
Ann Thorac Surg; 1999 Apr; 67(4):1059-64. PubMed ID: 10320251
[TBL] [Abstract][Full Text] [Related]
2. Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances.
Massoudy P; Zahler S; Freyholdt T; Henze R; Barankay A; Becker BF; Braun SL; Meisner H
J Thorac Cardiovasc Surg; 2000 Mar; 119(3):566-74. PubMed ID: 10694618
[TBL] [Abstract][Full Text] [Related]
3. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass.
Zahler S; Massoudy P; Hartl H; Hähnel C; Meisner H; Becker BF
Cardiovasc Res; 1999 Mar; 41(3):722-30. PubMed ID: 10435044
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release of proinflammatory cytokines.
Freyholdt T; Massoudy P; Zahler S; Henze R; Barankay A; Becker BF; Meisner H
J Cardiovasc Pharmacol; 2003 Sep; 42(3):372-8. PubMed ID: 12960682
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of systemic inflammatory response with sodium nitroprusside in open heart surgery.
Göl MK; Nisanoğlu V; Işcan Z; Balci M; Kandemir O; Taşdemir O
J Cardiovasc Surg (Torino); 2002 Dec; 43(6):803-9. PubMed ID: 12483170
[TBL] [Abstract][Full Text] [Related]
6. Significant leukocyte and platelet retention during pulmonary passage after declamping of the aorta in CABG patients.
Massoudy P; Zahler S; Becker BF; Braun SL; Barankay A; Richter JA; Meisner H
Eur J Med Res; 1999 May; 4(5):178-82. PubMed ID: 10336406
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
8. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.
Wan S; Marchant A; DeSmet JM; Antoine M; Zhang H; Vachiery JL; Goldman M; Vincent JL; LeClerc JL
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):469-77. PubMed ID: 8583822
[TBL] [Abstract][Full Text] [Related]
9. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass.
Massoudy P; Zahler S; Becker BF; Braun SL; Barankay A; Meisner H
Chest; 2001 Jan; 119(1):31-6. PubMed ID: 11157581
[TBL] [Abstract][Full Text] [Related]
10. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery.
Baksaas ST; Flom-Halvorsen HI; Ovrum E; Videm V; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):107-17. PubMed ID: 10338322
[TBL] [Abstract][Full Text] [Related]
11. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.
Wan S; DeSmet JM; Barvais L; Goldstein M; Vincent JL; LeClerc JL
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):806-11. PubMed ID: 8800171
[TBL] [Abstract][Full Text] [Related]
12. The effect of leukocyte reduction filters on inflammatory mediator release during coronary artery bypass grafting.
Bartkowiak M; Bugajski P; Siminiak T; Kalawski R
Kardiol Pol; 2013; 71(9):945-50. PubMed ID: 24065423
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting.
Sawa Y; Matsuda H; Shimazaki Y; Kaneko M; Nishimura M; Amemiya A; Sakai K; Nakano S
J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1125-31. PubMed ID: 7983882
[TBL] [Abstract][Full Text] [Related]
14. Reduction of pro-inflammatory cytokine levels and cellular adhesion in CABG procedures with separated pulmonary and systemic extracorporeal circulation without an oxygenator.
Massoudy P; Zahler S; Tassani P; Becker BF; Richter JA; Pfauder M; Lange R; Meisner H
Eur J Cardiothorac Surg; 2000 Jun; 17(6):729-36. PubMed ID: 10856868
[TBL] [Abstract][Full Text] [Related]
15. IL-8 concentration in coronary sinus blood during early coronary reperfusion after ischemic arrest.
Lango R; Anisimowicz L; Siebert J; Rogowski J; Bakowska A; Mroziński P; Narkiewicz M
Eur J Cardiothorac Surg; 2001 Sep; 20(3):550-4. PubMed ID: 11509278
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting.
Gu YJ; Mariani MA; van Oeveren W; Grandjean JG; Boonstra PW
Ann Thorac Surg; 1998 Feb; 65(2):420-4. PubMed ID: 9485239
[TBL] [Abstract][Full Text] [Related]
18. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting.
Corcoran TB; Engel A; Sakamoto H; O'Callaghan-Enright S; O'Donnell A; Heffron JA; Shorten G
J Cardiothorac Vasc Anesth; 2004 Oct; 18(5):592-604. PubMed ID: 15578470
[TBL] [Abstract][Full Text] [Related]
19. Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass.
Prondzinsky R; Knüpfer A; Loppnow H; Redling F; Lehmann DW; Stabenow I; Witthaut R; Unverzagt S; Radke J; Zerkowski HR; Werdan K
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):760-6. PubMed ID: 15821641
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium.
Sawa Y; Ichikawa H; Kagisaki K; Ohata T; Matsuda H
J Thorac Cardiovasc Surg; 1998 Sep; 116(3):511-7. PubMed ID: 9731794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
